Lipid-lowering agents in chronic kidney disease: do fibrates have a role?

被引：0
|
作者：
Yuli Huang
Yunzhao Hu
机构：
[1] the Affiliated Hospital at Shunde (the First People's Hospital of Shunde),Department of Cardiology
[2] Southern Medical University,undefined
来源：
Nature Reviews Cardiology | 2013年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：547 / 547
相关论文
共 50 条
  • [21] MECHANISMS OF LIPID-LOWERING AGENTS
    SIRTORI, CR
    MANZONI, C
    LOVATI, MR
    CARDIOLOGY, 1991, 78 (03) : 226 - 235
  • [22] Lipid-Lowering Agents and Hepatotoxicity
    Demyen, Michael
    Alkhalloufi, Kawtar
    Pyrsopoulos, Nikolaos T.
    CLINICS IN LIVER DISEASE, 2013, 17 (04) : 699 - +
  • [23] PRESCRIBING LIPID-LOWERING AGENTS
    WHEATLEY, G
    BRITISH JOURNAL OF GENERAL PRACTICE, 1995, 45 (395): : 329 - 329
  • [24] Discontinuing lipid-lowering agents
    Davis, George F.
    JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (03) : 619 - 619
  • [25] New lipid-lowering Agents
    Sinning, David
    Landmesser, Ulf
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (02) : 92 - 101
  • [26] Lipid-lowering agents and myopathy
    Wortmann, RL
    CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (06) : 643 - 647
  • [27] Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review
    Pryor, Joseph B.
    Weber, Bo R.
    Weber, Jacob, V
    Lockridge, Joseph B.
    Olyaei, Ali J.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (09) : 431 - 441
  • [28] Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review
    Joseph B. Pryor
    Bo R. Weber
    Jacob V. Weber
    Joseph B. Lockridge
    Ali J. Olyaei
    Drugs & Therapy Perspectives, 2019, 35 : 431 - 441
  • [29] Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Saha, Sandeep A.
    Arora, Rohit R.
    CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (04) : 270 - 276
  • [30] Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease
    Abe, Masanori
    Maruyama, Noriaki
    Yoshida, Yoshinori
    Ito, Midori
    Okada, Kazuyoshi
    Soma, Masayoshi
    ENDOCRINE JOURNAL, 2011, 58 (08) : 663 - 674
12345